Author:
Punzalan Felix Eduardo R.,Cutiongco – de la Paz Eva Maria C.,Nevado Jose Jr. B.,Magno Jose Donato A.,Ona Deborah Ignacia D.,Aman Aimee Yvonne Criselle L.,Tiongson Marc Denver A.,Llanes Elmer Jasper B.,Reganit Paul Ferdinand M.,Tiongco Richard Henry P.,Santos Lourdes Ella G.,Aherrera Jaime Alfonso M.,Abrahan Lauro L.,Agustin Charlene F.,Bejarin Adrian John P.,Sy Rody G.
Funder
Philippine Council for Health Research and Development
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference24 articles.
1. Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm Hg, 1990–2015;Forouzanfar;JAMA,2017
2. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines;Whelton;J Am Coll Cardiol,2018
3. Pharmacology and mechanisms of action of calcium-channel blockers;Katz;J Clin Hypertens,1986
4. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine;Kes;Curr Med Res Opin,2003
5. Evidence-based evaluation of calcium channel blockers for hypertension: equality of mortality and cardiovascular risk relative to conventional therapy;Opie;J Am Coll Cardiol,2002
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献